COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $507,906 | -34.8% | 135,804 | +19.3% | 0.00% | – |
| Q2 2023 | $778,938 | 0.0% | 113,880 | 0.0% | 0.00% | – |
| Q1 2023 | $778,938 | -6.3% | 113,880 | +8.5% | 0.00% | – |
| Q4 2022 | $831,395 | -99.8% | 104,974 | +85.8% | 0.00% | – |
| Q3 2022 | $542,982,000 | +19.3% | 56,502 | -10.1% | 0.00% | – |
| Q2 2022 | $455,243,000 | -55.3% | 62,879 | -20.3% | 0.00% | – |
| Q1 2022 | $1,018,741,000 | -19.1% | 78,911 | 0.0% | 0.00% | – |
| Q4 2021 | $1,259,421,000 | -0.7% | 78,911 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,268,099,000 | +16.2% | 78,911 | 0.0% | 0.00% | – |
| Q2 2021 | $1,091,339,000 | -64.7% | 78,911 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $3,089,268,000 | -92.1% | 211,449 | -90.6% | 0.00% | -94.4% |
| Q4 2020 | $39,172,887,000 | +25.8% | 2,253,906 | +32.7% | 0.02% | +5.9% |
| Q3 2020 | $31,147,224,000 | -5.1% | 1,698,322 | -7.6% | 0.02% | -15.0% |
| Q2 2020 | $32,811,677,000 | +8.8% | 1,837,160 | -1.2% | 0.02% | -9.1% |
| Q1 2020 | $30,155,853,000 | -12.7% | 1,859,177 | -3.0% | 0.02% | +4.8% |
| Q4 2019 | $34,524,120,000 | +8.5% | 1,917,474 | +22.1% | 0.02% | 0.0% |
| Q3 2019 | $31,817,945,000 | -5.2% | 1,570,481 | +3.4% | 0.02% | -12.5% |
| Q2 2019 | $33,559,139,000 | +56.5% | 1,518,513 | -3.4% | 0.02% | +50.0% |
| Q1 2019 | $21,440,580,000 | +80.2% | 1,571,890 | +19.6% | 0.02% | +60.0% |
| Q4 2018 | $11,898,027,000 | -42.9% | 1,314,699 | +4.2% | 0.01% | -33.3% |
| Q3 2018 | $20,820,313,000 | +13.3% | 1,261,837 | -3.9% | 0.02% | +7.1% |
| Q2 2018 | $18,381,622,000 | +25.9% | 1,312,973 | -0.6% | 0.01% | +16.7% |
| Q1 2018 | $14,600,034,000 | +19.0% | 1,321,270 | -5.2% | 0.01% | +20.0% |
| Q4 2017 | $12,264,217,000 | -30.5% | 1,393,661 | +5.5% | 0.01% | -37.5% |
| Q3 2017 | $17,634,697,000 | -11.7% | 1,320,951 | -5.1% | 0.02% | -15.8% |
| Q2 2017 | $19,963,950,000 | +4.8% | 1,391,216 | +54.5% | 0.02% | 0.0% |
| Q1 2017 | $19,041,706,000 | +134746.7% | 900,317 | +79.5% | 0.02% | +18.8% |
| Q4 2016 | $14,121,000 | +2701.8% | 501,673 | +2562.1% | 0.02% | +1500.0% |
| Q3 2016 | $504,000 | +148.3% | 18,845 | +97.0% | 0.00% | – |
| Q1 2016 | $203,000 | -23.1% | 9,567 | -16.8% | 0.00% | – |
| Q4 2015 | $264,000 | – | 11,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |